Skip to main content

Oral Lichen Planus

3
Pipeline Programs
3
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
2
0
0
1
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

ADEL
ADELKorea - Seoul
1 program
1
triamcinolone acetonidePhase 41 trial
Active Trials
NCT03572959Completed24Est. May 2017
Lipella Pharmaceuticals
1 program
1
LP-10Phase 21 trial
Active Trials
NCT06233591Active Not Recruiting24Est. Jun 2025
Sandoz
SandozAustria - Kundl
1 program
1
Pimecrolimus 1% creamPhase 21 trial
Active Trials
NCT00297037Completed21Est. Feb 2009

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
ADELtriamcinolone acetonide
Lipella PharmaceuticalsLP-10
SandozPimecrolimus 1% cream

Clinical Trials (3)

Total enrollment: 69 patients across 3 trials

NCT03572959ADELtriamcinolone acetonide

Management of Pain in Oral Lichen Planus

Start: Dec 2016Est. completion: May 201724 patients
Phase 4Completed

Evaluating LP-10 in Subjects With OLP

Start: Jul 2024Est. completion: Jun 202524 patients
Phase 2Active Not Recruiting
NCT00297037SandozPimecrolimus 1% cream

Pimecrolimus Cream for Oral Lichen Planus

Start: Aug 2005Est. completion: Feb 200921 patients
Phase 2Completed

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.